Neumora Therapeutics, Inc.

US$0.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NMRAHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (65.79%)
Div yield —
ROE (187.11%)
Biotechnology
Beta (5Y) 3.14
PE TTM —
TSR TTM (83.33%)
Mkt cap US$94.57M
ROIC (85.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.615
22.21%
(58.24%)
Hold 6|11|1|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
23.20%
23.77%
21.87%
23.47%
Revenue$M
6.168
6.331
6.482
6.796
0.23%
5.80%
3.74%
11.97%
Peers (US$94.57M)
Cap (US$)
PE
94.71M
90.59x
Capital
TTM
5Y
10Y
Leveragex
1.662
0.041
0.038
EBIT/Intx
0.192
0.132
0.132
Own earn%
30.45
165.58
107.51
Sh yield%
40.87
51.19
49.66
Owners
Insiders/Inst%
12.38
33.72
Short interest%
2.71
SBC / revenue%
5.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
19–28
$1 testx
−0.1
Incr. ROIC%
3